NONINVASIVE IMAGING PROTOCOLS TO DETECT AND MONITOR CAROTID ATHEROSCLEROSIS PROGRESSION

被引:20
作者
MERCURI, M
机构
[1] Division of Vascular Ultrasound Research, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC
关键词
ATHEROSCLEROSIS; CAROTID ARTERY; INTIMA-MEDIA THICKNESS; ULTRASOUND IMAGING; CLINICAL TRIALS;
D O I
10.1093/ajh/7.7.23S
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
It has been shown that B-mode ultrasound imaging is a valid and reliable technique to measure arterial wall thickness. Based on the results of early validation studies and relatively small-scale investigations, large-scale epidemiologic studies using high-resolution ultrasonography were designed to provide information on the association of wall thickness and cardiovascular risk factors, and to determine the prevalence, extent, and severity of peripheral atherosclerosis. Recent reports indicate that ultrasonographic endpoints correlate with the most important cardiovascular risk factors. Furthermore, noninvasive carotid endpoints have been shown to be predictive of clinical atherosclerosis status with a high degree of confidence. B-mode ultrasonography has also been used to evaluate prospectively the natural history of peripheral atherosclerosis by monitoring lesion growth over time. Recently, ultrasonographic measurements of the arterial wall have been chosen as the primary and secondary endpoints for several clinical trials of the antiatherogenic effects of behavioral and pharmacologic interventions on major cardiovascular risk factors such as hypercholesterolemia and hypertension.
引用
收藏
页码:S23 / S29
页数:7
相关论文
共 27 条
[1]  
Walton W.K., Possible recognition of atherosclerosis regression, pp. 187-200, (1984)
[2]  
Malinov M.R., Regression of atherosclerosis in humans: Anatomical evidence from postmortem studies, pp. 329-337, (1984)
[3]  
Bond M.G., Purvis C., Mercuri M., Antiatherogenic properties of calcium antaonists, J Cardiovasc Pharmacol, 17, pp. S87-S93, (1991)
[4]  
Bond M.G., Mercuri M., Nichols F.T., Et al., Antiatherosclerosis clinical trials using calcium antagonists, J Vase Med Biol, 3, pp. 329-401, (1991)
[5]  
Bond G.M., Adams M.R., Bullock B.C., Complication factors in evaluating coronary artery atherosclerosis, Artery, 9, pp. 21-29, (1981)
[6]  
Glagov S., Weisenberg E., Zarins C.K., Et al., Compensatory enlargement of human atherosclerotic coronary arteries, N Engl J Med, 316, pp. 1371-1375, (1987)
[7]  
Kremkau F.W., Diagnostic Ultrasound. Principles and Instruments, (1993)
[8]  
Zwiebel W.J., Introduction to Vascular Ultrasonography, (1986)
[9]  
Pignoli P., Tremoli E., Poli A., Et al., Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging, Circulation, 74, pp. 1399-1406, (1986)
[10]  
Bond M.G., Wilmoth S.K., Enevold G.L., Strickland H.L., Detection and monitoring of asymptomatic atherosclerosis in clinical trials, Am J Med, 86, pp. 33-36, (1989)